Safety Rates Drug Report: PACLITAXEL. Neoplasm recurrence adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: PACLITAXEL. Injury: Neoplasm recurrence Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 15 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
125809371	PACLITAXEL.	Neoplasm recurrence	INTERCHEM	56.00 YR		0	20160721	CN
126706221	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706231	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706291	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706321	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706341	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706471	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706491	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706521	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706541	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706571	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706601	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706621	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706721	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL
126706861	PACLITAXEL.	Neoplasm recurrence	CIPLA	0.00		0	20160822	NL

|< 1/2 << Previous Page Page 1

Total Records: 15 Number of Pages: 1

Execution Time: 0.020377159118652 seconds (ucode:5119537). Developed by: James D. Barger